Schiedner Gudrun, Hertel Sabine, Johnston Marion, Biermann Volker, Dries Volker, Kochanek Stefan
Center for Molecular Medicine (ZMMK), University of Cologne, D-50931 Cologne, Germany.
J Virol. 2002 Feb;76(4):1600-9. doi: 10.1128/jvi.76.4.1600-1609.2002.
In high-capacity adenovirus (HC-Ad) vectors the size and/or composition of the vector genome influences vector stability during production and the expression profile following gene transfer. Typically, an HC-Ad vector will contain both a gene or an expression cassette and stuffer DNA that is required to balance the final vector genome to a size of between 27 and 36 kb. To gain an improved understanding of factors that may influence gene expression from HC-Ad vectors, we have generated a series of vectors that carry different combinations of human alpha-1 antitrypsin (hAAT) expression constructs and stuffer DNAs. Expression in vitro did not predict in vivo performance: all vectors expressed hAAT at similar levels when tested in cell culture. Hepatic expression was evaluated following in vivo gene transfer in C57BL/6J mice. hAAT levels obtained from genomic DNA were significantly higher than levels achieved with small cDNA expression cassettes. Expression was independent of the orientation and only marginally influenced by the location of the expression cassette within the vector genome. The use of lambda stuffer DNA resulted in low-level but stable expression for at least 3 months when higher doses were applied. A potential matrix attachment region element was identified within the hAAT gene and caused a 10-fold increase in expression when introduced in an HC-Ad vector genome carrying a phosphoglycerate kinase (pgk) hAAT cDNA construct. We also illustrate the influence of the promoter on anti-hAAT antibody formation in C57BL/6J mice: a human cytomegalovirus but not a pgk promoter resulted in an anti-hAAT antibody response. Thus, the overall design of HC-Ad vectors may significantly influence amounts and duration of gene expression at different levels.
在高容量腺病毒(HC-Ad)载体中,载体基因组的大小和/或组成会影响生产过程中的载体稳定性以及基因转移后的表达谱。通常,HC-Ad载体将同时包含一个基因或一个表达盒以及填充DNA,填充DNA是将最终载体基因组平衡至27至36 kb大小所必需的。为了更好地理解可能影响HC-Ad载体基因表达的因素,我们构建了一系列携带不同组合的人α-1抗胰蛋白酶(hAAT)表达构建体和填充DNA的载体。体外表达并不能预测体内性能:在细胞培养中测试时,所有载体均以相似水平表达hAAT。在C57BL/6J小鼠体内进行基因转移后评估肝脏表达。从基因组DNA获得的hAAT水平显著高于小cDNA表达盒所达到的水平。表达与方向无关,并且仅略微受表达盒在载体基因组内位置的影响。当应用较高剂量时,使用λ填充DNA可导致至少3个月的低水平但稳定的表达。在hAAT基因内鉴定出一个潜在的基质附着区域元件,当将其引入携带磷酸甘油酸激酶(pgk)hAAT cDNA构建体的HC-Ad载体基因组中时,表达增加了10倍。我们还阐述了启动子对C57BL/6J小鼠中抗hAAT抗体形成的影响:人巨细胞病毒启动子而非pgk启动子导致了抗hAAT抗体反应。因此,HC-Ad载体的整体设计可能会在不同水平上显著影响基因表达的量和持续时间。